A member of the World Bank loaned Jubilant Pharma $147.5 million to help the India-based company supply affordable drugs. Jubilant will use some of the cash to improve its generic drug manufacturing plants in India while also tapping the bank's emerging market healthcare expertise. "[The bank's] contribution goes beyond financing to help us strengthen our quality assurance and risk mitigation," Jubilant Chairman Shyam Bhartia said in a statement. Article